94. Primary sclerosing cholangitis Clinical trials / Disease details
Clinical trials : 148 / Drugs : 118 - (DrugBank : 39) / Drug target genes : 18 - Drug target pathways : 141
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03216876 (ClinicalTrials.gov) | September 2017 | 5/1/2016 | A Study Of Ursolic Acid For Primary Sclerosing Cholangitis | An Open-Label Study Of Ursolic Acid For Primary Sclerosing Cholangitis | Primary Sclerosing Cholangitis | Drug: Ursolic acid | University of California, Davis | NULL | Withdrawn | 18 Years | 70 Years | All | 0 | Phase 1 | United States |